Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells

Eur J Pharmacol. 2021 Mar 15:895:173881. doi: 10.1016/j.ejphar.2021.173881. Epub 2021 Jan 19.

Abstract

Objectives: Volume-regulated anion channels (VRACs), expressed in various cells, play an important role in cell volume regulation. Despite being physiologically defined almost half a century ago, only the molecular candidates of VRAC, TMEM16A, LRRC8A, and bestrophin-1 (BEST1), are known. Here, we aimed to explore the functional significance of VRAC in, HST-1, an oral squamous cell carcinoma (OSCC) cell line.

Methods: Cell proliferation assays, RT-PCR, Western blot, and flow cytometry were used to estimate changes in gene expression and cell proliferation. Ion channel activity was recorded using the patch-clamp technique. Specific genes were knocked-down by siRNA assays.

Results: VRAC, identified as a hypotonicity-induced current, was highly functional and associated with the proliferation of HST-1 cells but not of HaCaT (a normal keratinocyte) cells. The pharmacological profile of VRAC in HST-1 was similar to that reported previously. DCPIB, a specific VRAC inhibitor, completely inhibited VRAC and proliferation of HST-1 cells, eventually leading to apoptosis. VRAC in HST-1 was attenuated by the knockdown of TMEM16A and LRRC8A, while knockdown of BEST1 affected cell proliferation. In situ proximity ligation assay showed that TMEM16A and LRRC8A co-localized under isotonic conditions (300 mOsM) but were separated under hypotonic conditions (250 mOsM) on the plasma membrane.

Conclusions: We have found that VRAC acts to regulate the proliferation of human metastatic OSCC cells and the composition of VRAC may involve in the interactions between TMEM16A and LRRC8A in HST-1 cells.

Keywords: Cell proliferation; DCPIB; LRRC8A; Oral cancer; TMEM16A; Volume-regulated chloride channel.

MeSH terms

  • Anoctamin-1 / antagonists & inhibitors
  • Anoctamin-1 / genetics
  • Anoctamin-1 / metabolism*
  • Antineoplastic Agents / pharmacology
  • Apoptosis
  • Bestrophins / genetics
  • Bestrophins / metabolism
  • Cell Line, Tumor
  • Cell Proliferation* / drug effects
  • Chloride Channels / antagonists & inhibitors
  • Chloride Channels / genetics
  • Chloride Channels / metabolism*
  • Cyclopentanes / pharmacology
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Indans / pharmacology
  • Ion Channel Gating
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Protein Binding
  • Signal Transduction
  • Squamous Cell Carcinoma of Head and Neck / drug therapy
  • Squamous Cell Carcinoma of Head and Neck / genetics
  • Squamous Cell Carcinoma of Head and Neck / metabolism*
  • Squamous Cell Carcinoma of Head and Neck / secondary
  • Tongue Neoplasms / drug therapy
  • Tongue Neoplasms / genetics
  • Tongue Neoplasms / metabolism*
  • Tongue Neoplasms / pathology

Substances

  • 4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-one-5-yl)oxybutyric acid
  • ANO1 protein, human
  • Anoctamin-1
  • Antineoplastic Agents
  • BEST1 protein, human
  • Bestrophins
  • Chloride Channels
  • Cyclopentanes
  • Indans
  • LRRC8A protein, human
  • Membrane Proteins
  • Neoplasm Proteins